 |
 |
PSI One Day Meeting about RWE: Generalisability of Treatment Comparisons for Decision Making 18th September 2018 Lily, Bad Homburg, Germany Full details and register here: https://psiweb.org/events/event-item/2018/09/18/default-calendar/psi-one-day-meeting-and-workshop-real-world-evidence-generalisability-of-treatment-comparisons-for-decision-making <https://psiweb.org/events/event-item/2018/09/18/default-calendar/psi-one-day-meeting-and-workshop-real-world-evidence-generalisability-of-treatment-comparisons-for-decision-making> Real World Evidence data are an increasingly valuable resource in drug development. One area where this data is being used regularly is in generalisability of treatment comparisons. This PSI event will focus on: •new advances in indirect comparisons, •generalizability approaches for clinical trial data into the real world, and •cross-design approaches combining observational and randomized data. The aims of the event include: •sharing what research approaches are currently discussed, •obtaining feedback and insights from members of HTA bodies. KEY TOPICS Indirect comparisons with and without adjustment for patient characteristics and related approaches Sarah Böhme (Pfizer), David Phillippo (University Bristol) Generalizability of clinical trial data into real life settings Yann Ruffieux (University Bern), Alan Brnabic (Lilly) Cross-design approaches combining observational and clinical trial data , Mark Belger (Lilly), Keith Abrams (University Leicester) Break out sessions on: •Bucher vs matching adjusted indirect comparisons and further refinements of these •Generalizability of clinical trial data into real life settings •Cross-design approaches combining observational and clinical trial data Panel discussion including Alexander Schacht (Lilly), Carsten Schwenke (SCOSSIS), Ralf Bender (IQWiG), Nicky Welton (University Bristol), Keith Abrams (University Leicester), Chrissie Fletcher (Amgen), Mark Belger (Lilly) You may leave the list at any time by sending the command SIGNOFF allstat to [log in to unmask], leaving the subject line blank.